Intro china chc & thc market reports 2013

1Loudon Far EastLoudon Far East
Multi-client reports prepared for the healthcare industry
By
Date: June 2013
Introduction to “2013 China Broad Market Reports”
CHC & THC Markets Landscape Studies

Contents
Report Objectives & Methodology
Sampling Plan
Illustrative Outputs
Contents of Report
Cost of Reports

Key Questions to Identify China CHC & THC Market Opportunities
These questions are answered in the reports
• Size of CHC/THC segments, potential, growth & which provinces to target?
• Patients profile: healthcare coverage, objectives of the visits?
• What diseases are diagnosed in CHCs & THCs?
• What diseases are treated in CHCs & THCs? (e.g.: HRT?, BPH?, HBV?, etc)
• Hospital specialties & physicians’ unmet needs, what can MNCs do?
• Patients unmet needs & what can MNCs do?
• Prescription switching & brand loyalty ?
• Patients consulting processes: diagnosis, initiation, retention, leverage points for MNCs?
• Patients perception of imported/JV products by TAs & premium they are willing to pay?
• Is e-marketing the right approach in China to target CHCs & THCs?
1
2
3
4
5
6
7
8
9
10

What’s New in 2013 Reports?
Compared to 2010 reports “China CHC Market Landscape Studies”
• Add a brand new report about China THC Market
• Update the CHC & THC market facts based upon the latest data and information
• Incorporate the latest policies regarding CHCs & THCs ( i.e.: Listing, tendering, etc.)
• Increase the sample size of physicians and patients interviews:
– from 2,700 to 6,000 patients FTF Interviews
– from 270 to 290 physicians FTF Interviews
• Integrated “e-marketing opportunities report” into both CHC & THC individual reports
• Lower subscription fees vs 2010:
– China CHC & THC Market Overview – Supply & Demand Sides 100,000 RMB
incl. additional valuable information on THC market but same subscription as in 2010.
– China CHC Market Opportunities – Physicians & Patients Perspectives TBD
Integrate information on both Physicians AND Patients (2010 value 300,000 RMB)
and e-marketing opportunities report information (2010 value: 70,000 RMB)
– China THC Market Opportunities – Physicians & Patients Perspectives TBD
New report available (not available in 2010), integrate information on e-marketing opportunities

Wide Range of Data Sources & Resources
Loudon’s Data Collection Loudon Databases
Hospital Database
• MOH hospital databases
• CHC database
• THC databases
• PLA hospital database
City Database
• Demography
• Social Economics
• Healthcare expenditure
• Healthcare data base
Primary and secondary marketing research
Desk Research
• Loudon database
• Public information in provincial MOH and other
domains
Qualitative In-Depth Interviews (IDIs)
• 12 IDIs with CHC physicians
• 12 IDIs with CHC patients
• 12 IDIs with THC physicians
• 12 IDIs with THC patients
Quantitative Face to Face Interviews (FTFs)
• 3,000 FTFs with CHC patients
• 3,000 FTFs with THC patients
• 290 FTFs with physicians

• Patients caseload & Diseases type
• Key drivers to go to CHC and THC
• Satisfaction of CHC, THC services and unmet
needs
• Staff profile and specialties set up in CHC, THC
• Numbers of medicines (WM, TCMs) in pharmacies
• Typical CHC, THC physicians prescription
behaviors
• Physician information channel and unmet needs
• Number of CHC and hospitals, physicians,
hospital beds by provinces
• CHC, THC out patients caseload by provinces
• Population, aged population, GDP income
status , Healthcare expenditures by provinces
• CHC, THC out patient visit average
expenditure by provinces
• Segment of CHC and THC market by size,
key parameters of suppliers and demanders.
• Finalize
research and
analysis plans
• Review of
internal data
and reports
• Develop
analysis plan
Phase:
Module:
Deliverable: • Survey plans
• Guidelines
• Question-
naires
Physician interviews
• 12 In-depth interviews with CHC physicians
• 12 In-depth interviews with THC physicians
• 290 face to face interviews with physicians
a
Preparation Phase I: Market Landscape Phase II: Market Opportunities
The Landscape Study are Divided Into Two Phases
Public information, Loudon databases, interviews of physicians and patients
Patient interviews
• 12 In-depth interviews with CHC patients
• 12 In-depth interviews with CHC patients
• 6,000 face to face interviews with patients
Desk Survey
•Loudon database
•Public information in provincial MOH and other
domains
a
Data Base
• MOH hospital databases
• CHC database
• THC databases
• PLA hospital database
b b

Contents
Sampling Plan
Contents of Report
Cost of Reports

Data Collection Plan Physician and Patient Interviews (1/2)
290 IDIs with physicians and 6,000 FTFs with patients
THC
Tier I
Tier II
Physician
Numbers of Interviews
Beijing
Wuhan
15
8
5
8
8
CHC
Shanghai
Guangzhou
Shenyang
15
15
8
8
15
Physician
8Chengdu 8
8Xi’an
300
300
160
160
300
Patients
160
Patients
300
160
100
160
160
160
160
Nanjing
8
8
160
160 5 100
Tier III
Foshan 6
6Taizhou
6
6
6Baoding 6
6Taiyuan
120
120
120
120
120
120
1206 120

Tier IV
Tier V
Data Collection Plan Physician and Patient Interviews (2/2)
290 IDIs with physicians and 6,000 FTFs with patients
Kunshan
Xianyang
6
6
6
5
6
Fushun
Huizhou
Suining
4
4
4
3
4
5Jingmen 3
5Yuyao
80
80
80
75
80
75
120
120
120
110
120
110
110
Dandong
3
3
75
75 5 110
Tier VI
Jieshou 3
3Penglai
2
2
3Honghu 2
3DJY
50
50
50
75
75
75
752 50
145Total 3,000145 3,000
THC
Physician
Numbers of Interviews
CHC
Physician Patients Patients

Study Was Conducted In 24 Cities & 9 Provinces
Western Medicine Expenditure ranking from No. 1 to No. 626
Source: Loudon in house database
Shanghai
Wuhan
Chengdu
Tier I city
Urban pop: 13.5 Mn .
Urban disposable
income/cap: RMB 23.6 K
Tier II city
Urban pop.: 6.9 .
Urban disposable
Tier I city
Urban pop: 8.3 Mn .
Beijing
Tier I city
.
Urban disposable
Shenyang
Guangzhou
Nanjing
Tier II city
Urban pop.: 7.4 Mn .
Urban disposable
Suining
Tier II city
Urban disposable
Tier II city
Urban disposable
Tier II city
Urban pop: 7.4 Mn .
Urban disposable
Tier VITier VTier I Tier II Tier III Tier IV
Taiyuan
Taizhou
Baoding
Kunsan
Xi’an
Xianyang
Jingmen
Yuyao
Jieshou
DJY
Foshan
Fushun
Huizhou
Dandong
Penglai
Honghu
Tier I city
Pop(Mil.)
Ranking
WME
Shanghai 2.30 1
Beijing 1.96 2
Guangzhou 1.27 3
Tier II city
Pop(Mil.)
Ranking
WME
Wuhan 0.98 6
Nanjing 0.81 7
Chengdu 1.40 9
Shenyang 0.81 11
Xi'an 0.85 19
Tier III city
Pop(Mil.)
Ranking
WME
Foshan 0.72 29
Tiayuan 0.42 34
Taizhou 0.46 38
Baoding 1.12 50
Tier IV city
Pop(Mil.)
Ranking
WME
Huizhou 0.46 62
Kunsan 0.16 106
Xianyang 0.51 112
Fushun 0.21 158
Tier V city
Pop(Mil.)
Ranking
WME
Yuyao 0.10 182
Suining 0.33 184
Jingmen 0.29 203
Dandong 0.24 204
Tier VI city
Pop(Mil.)
Ranking
WME
Penglai 0.045 356
DJY 0.066 460
Jieshou 0.056 538
Honghu 0.082 626

Contents
Sampling Plan
Contents of Report
Cost of Reports

25.0
2.0
33.8
16.0
46.2
25.0
15.5
9.0
23.0
13.0
9.0
33.8 24.0
46.2
30.0
15.5
7.0
17.0
8.0
3.0
33.0 24.0
46.0
36.0
16.0
11.0
18.0
Pharma Market & Hospital Segments in Shanxi
CHC only accounts for 2.0% of total Shanxi pharma market
Shanxi Hospital Segments
Illustrative
Source: Loudon Analysis, MOPH & CHC Database, Dummy slides
PLA Hospitals (S3) (N=5)
IMS Hospital Audit
RMB
(Bn.)
MS
MOH Hos
<100 Beds
(S2) (N=720)
Community
Health Center
(Station)
(S4) (N=530)
S1
S3S2 S4
MOH Hos ≥100 beds
(S1) (N=300)
TOT
Size (beds)
Patient Caseload by Segments
WME by Segments
Shanxi Pharma Market Segments
Hospital Beds Number by Segments
>=800
500-799
300-499
<300
CHC (Station)
THC
Size (beds)
>=800
500-799
300-499
<300
CHC (Station)
THC
Size (beds)
>=800
500-799
300-499
<300
CHC (Station)
THC
2.50 0.51 0.10 0.07 0.20 3.38
74.0% 15.1% 3.0% 2.1% 5.9% 100.0%
1.0
2.0
2.0
16.0
46.0
33.0
(% of hospitals) (% of beds)
(% of hospitals) (% of patient caseload)
(% of hospital) (% of WME)
1.0
2.0
2.0
16.0
46.0
33.0
1.0
2.0
2.0
16.0
46.0
33.0
Township
Health Center
(S5) (N=1500)
S5

Top 400 CHCs Account for 50% of CHC Market
Market concentration is in line with primary care chronicle disease market
0%
20%
40%
60%
80%
100%
0 20 40 60 80 100 120 140 160 180 200 220 240 260
Hyperlipidemia
HRT
A rare disease
Oncology
HBP
CHC Market Compared with 5 TA Markets
% of WME
Rank by Hospital Potential
Market Share of Top 50 hospitals Top Hospitals to Cover 50% Market
HBP 15.1% 349 hospitals
Hyperlipidemia 14.5% 330 hospitals
HRT 33.0% 112 hospitals
Oncology 52.8% 43 hospitals
A rare disease 72.3% 20 hospitals
CHC 19.6% 400 CHCs
0%
20%
40%
60%
80%
100%
0 20 40 60 80 100 120 140 160 180 200 220 240 260
HBP
% of WME
Rank by Hospital Potential
MOH Hos <100 Beds
MOH Hos ≥100 beds
CHC Market Compared with MOH Hos Markets
CHC CHC
HRT
Illustrative

CHC WME Potential Is Deviated Very Much Geographically
Normal Distribution Graph of CHC Market Size
Prioritized Market 1
Total CHC Market
Normal Distribution Graph of CHC Market SizeOptimize Your Sales Force Resource
0
4
8
12
16
0
10
20
30
40
50
60
Group I II III IV V Others
Number of sales call
#ofsalescalls
Maximize ROI of sales from
high potential CHCs
Sales, product prescriptions
Optimize the sales call
to most potential CHCs
WME(Mn.RMB)
1.080.700.680.57 0.85 WME (Mn. RMB)
Illustrative

Shanghai
WuhanChengdu
Beijing
Shenyang
Nanjing
Hangzhou
Tianjin
Chongqing
Ningbo
Shenzhen
Changsha
Jinan
Harbing
Zhengzhou
Fuzhou
Qingdao
Wenzhou
Xi’An
Kunming
Changchun
Guangzhou
Suzhou
Total #
of CHCs
WME
(Bn. RMB)
Top 23 cities
% of Total
CHC market
75.0%7,500 6.30
Shanghai
WuhanChengdu
Beijing
Shenyang
Nanjing
Hangzhou
Tianjin
Chongqing
Ningbo
Shenzhen
Changsha
Jinan
Harbing
Zhengzhou
Fuzhou
Qingdao
Wenzhou
Xi’An
Kunming
Changchun
Guangzhou
Suzhou
Total #
of CHCs
WME
(Bn. RMB)
Top 23 cities
Top 23 cities + 50 KM
% of Total
CHC market
75.0%
85.0%
7,500
14,900
6.30
7.00
Shanghai
WuhanChengdu
Beijing
Shenyang
Nanjing
Hangzhou
Tianjin
Chongqing
Ningbo
Shenzhen
Changsha
Jinan
Harbing
Zhengzhou
Fuzhou
Qingdao
Wenzhou
Xi’An
Kunming
Changchun
Guangzhou
Suzhou
Total #
of CHCs
WME
(Bn. RMB)
Top 23 cities
Top 23 cities + 50 KM
Top 23 cities + 2hr fast train
% of Total
CHC market
75.0%
85.0%
88.0%
7,500
14,900
16,900
6.30
7.00
7.50
Sources: Loudon analysis
China CHC Territory Management Strategy Scenario III: Focus on Top 23 Cities
CHC potential Analysis on its 2hrs economic circle
Illustrative

CHC Departments and Patient Size
Department
% of
CHCs
# of half
day
practice
per week
Weekly
Patient
Size in
OPD
Monthly
Patient
Size in
IPD
IM/General practice
大内科 / 全科
100.0 11.3 423.4 0.0
Precaution and health care
预防保健科
87.2 8.7 125.0 0.0
TCM (TCM&WM )
中医科（中西医结合科）
83.0 9.8 207.9 0.0
Gynecology (Obstetrics)
妇科（产科）
78.1 9.9 155.0 0.0
Surgery 外科 76.6 10.3 230.6 19.5
Dentistry 牙科 72.1 9.9 73.0 0.0
Acupuncture & massage
针灸推拿科
69.1 9.3 26.5 0.0
Physical therapy
理疗科
66.4 9.4 80.0 0.0
Pediatric 儿科 63.0 9.7 180.0 0.0
ENT 耳鼻喉科 53.2 8.8 113.0 0.0
Child care
儿童保健科
40.8 9.2 102.0 0.0
WM 西医科 1.5 10.3 347.5 0.0
Orthopedics 骨科 1.1 10.0 163.3 15.0
Dermatology 皮肤科 0.8 10.0 135.0 0.0
Pain management
疼痛科
0.4 10.0 250.0 20.0
ER 急诊科 0.4 14.0 118.3 0.0
Average Number of Departments Per CHC
In-patient Department Setting in CHC
CHCs Have an average of 8 Depts and 48% of CHCs Have In-Patient Dept.
All CHCs have set up IM/general practice
47.5
36.7
44.4
62.4
Total Tier I Tier II Tier III
% of CHC
with IPD
47.5% 36.7% 44.4% 62.4%
# of beds
per CHC
51.8 81.2 56.3 30.1
7.9 8.9 8.1 6.8
Source: Loudon analysis, Physician FTF interview SA, A1,A2, A4
More than 50% of hospitals have these Top 10 depts
Total Tier I Tier II Tier III
# of physicians/
CHC
31 40 35 17
# of physicians/
dept.CHC
3.9 4.5 4.3 2.5
Illustrative

Convenient Location is the Main Reason for Patients to Go to CHCs
Key Drivers for Visiting CHCs (% of patients)
Close to home
Medicines are cheaper than level II or III hospitals
Little illness, no necessary to visit big hospitals
Fewer patients, less time for queuing
Free registration fee
CHC physicians is nice and patient
Familiar with CHC physicians
Consult firstly, see if the disease is serious
Can ask for appointed drugs
Vaccination, no necessary to visit big hospitals
The service quality CHC been improved
Injection, no necessary to visit big hospitals
Take examination, no needs to visit big hospitals
Not strict, you can use the family member's card
Not strict, you can use several cards to avoid
medical insurance cap
8.7
7.2
5.7
5.2
4.3
84.7
31.1
30.0
24.9
18.4
17.3
13.5
11.0
1.5
1.3
Tier I Cities Tier II Cities Tie III Cities
87.2 84.1 82.7
35.7 37.9 19.7
23.7 36.3 29.9
30.2 29.7 14.7
15.9 23.3 15.9
12.7 23.0 16.3
15.3 11.4 13.8
8.2 14.0 10.8
18.4 4.6 3.0
8.2 7.9 5.4
5.0 6.3 5.9
1.9 8.3 5.2
3.6 5.2 4.1
2.2 1.6 0.7
2.7 0.8 0.3
Illustrative

Diagnosis % of Patients
Disease 1 60.0
Disease 2 10.0
Disease 3 5.0
Disease 4 4.8
Disease 5 3.8
Disease 6 3.6
Disease 7 3.2
Disease 8 3.0
Disease 9 1.1
50% of Patients Come for Diagnosis
75% patients are suffering from Disease 1, 2 and 3.
Source: Loudon analysis, patient FTF interview Q6, B1
Disease 10 1.0
Disease 11 0.9
Disease 12 0.7
Disease 13 0.7
Disease 14 0.6
Disease 15 0.6
Disease 16 0.5
Disease 17 0.4
Disease 18 0.4
Come for injection
4.0%
Bandage wound
3.0%
Total Patient
100%
Get vaccination in
POV
15.0%
Follow-up visit to
fill prescription
20.0%
Physician
examination
1.0%
Diagnosis
50.0%
Pregnancy and
Maternal care
2.0%
Routine exam only
5.0%
Others
10.0%
Indication or disease
Illustrative

Indication/TA % of Patients
Disease 1 30.0
Disease 2 15.0
Disease 3 9.0
Disease 4 6.0
Disease 5 3.4
Disease 6 3.4
Disease 7 3.2
Disease 8 2.1
Disease 9 1.8
20% of Patients Come to CHC for Filling Prescription
Major patients have chronic disease: Disease 1,2 and 3
Source: Loudon analysis, patient FTF interview Q6, B1
Disease 10 1.8
Disease 11 1.6
Disease 12 1.3
Disease 13 1.3
Disease 14 1.3
Disease 15 1.1
Disease 16 1.1
Disease 17 1.1
Disease 18 0.8
Indication or disease
Come for injection
4.0%
Bandage wound
3.0%
Total Patient
100%
Get vaccination in
POV
15.0%
Follow-up visit to
fill prescription
20.0%
Physician
examination
1.0%
Come for
diagnosis
50.0%
Pregnancy and
Maternal care
2.0%
Routine exam only
5.0%
Others
10.0%
Illustrative

27% of Physicians Feel Dissatisfied about their Career Development
Physicians required more Continuous Medical Education (CME)
Dissatisfied
Dissatisfied Neural Satisfied
Neural Satisfied
Tier I
Tier II
Tier III
• Dissatisfied organization chart of the
departments
• Insufficient investment on training
• Few opportunities of academic activities and
events
• Lack of expertise in specialized areas
• Too busy to learn
• Difficult to be promoted
• Help doctors to improve diagnosis experience
• Healthcare resource sharing with large hospitals
• More continuous education and academic
meetings
• Software application training
• Establish more expert consultation
• Medical information services of the latest
clinical development
• Attract more medical undergraduates
• More interactions of pharmaceutical companies
Satisfactions of Career Development Unmet needs
Suggestions
26.8%
22.2%
31.1%
27% of Physicians Feel
Dissatisfied
27.8%
Source: Loudon analysis, Physician FTF interview B20-21
Illustrative

18.4
63.0
63.0
81.4
18.6
3.6
93.0
93.0
96.6
3.4
Local Western Medicines Occupies CHC Market
A visit in CHC costs an average of 78 RMB
% of Imported and Local Medicines
(% of patients)
% of Western Medicines and TCM
(% of patients)
Medicine Expenditure and Medical Reimbursement
Total WM and Both WM
77.5
48.4
Total
Value of Rx
Out of
Pocket
Total
Value of Rx
Out of
Pocket
Total
Value of Rx
Out of
Pocket
Total
Value of Rx
Out of
Pocket
103.1
40.1
78.6
67.2
49.0
37.8
37.5%
61.2%
14.5%
22.8%
Total Patients Tier I Tier II Tier III
Both
TCM
WM
Total Local and Both Local
Both
Imported
Local
Illustrative

54.7 45.3
45% Physicians Switch Medicine when the Pre-determined are Unavailable
Most physicians consider “Medicine efficacy” when switch medicine
When Pre-determined Medicine
Unavailable
Medicine Switch Pattern
(% of patients)
Same category
different generic name
40.0%
Same generic name
different brand name
35.2%
Different category 24.8%
Switch different
brands among local
medicines
44.7%
Switch imported to
local medicine s
25.1%
Switch local to
imported medicines
17.4%
Switch different
brands among
imported medicines
12.8%
Follow the Prescription of High Level
Hospital
Not Rx and give other advices
Switch medicine
Not switch medicine
Switch medicine
63.2
60.3
45.6
32.4
29.4
22.1
19.1
10.3
4.4
Local or Imported
(% of patients)
Key Consideration When Switching Drugs
(% of physicians)
74.3 25.7
Medicine efficacy
Patient's disease status
Patient's economic
level
Medicine side effects
Clinical experience
Reimbursement
limitation
Patient's willingness
Prescription behavior
Medical rep's
promotion
Illustrative

More Examinations and High Treatment Skills are Required By CHC Patients
Satisfaction Level of CHC Service
(% of patients)
Extramely
Dissatisfied
10.2%
Extramely
Dissatisfied
0.6%
Somewhat
Satisfied
57.5%
Somewhat
Dissatisfied
4.7%
Neutral
27.0%
Satisfaction Level=3.7
Unmet Needs of CHC Service
(% of patients)
• Some examinations is not available and lack of
examination facilities in CHCs
28.9%
• CHC physicians' skill is a bit low, only to treat small
diseases.
28.8%
• No OPD practice at weekend or after work 14.0%
• No emergency room 13.5%
• Not RX many medicine as medical insurance
limitation
9.4%
• Appointed drugs are always unavailable 7.8%
• Bad attitude of physicians 4.4%
Illustrative

77.9
55.0
39.4
6.9
1.3
0.4
0.4
0.4
78% Physicians Think the State Investment Will Increase After “ 零差价” Policy
62% physicians in tier II cities assume more drug categories in CHC after EDL applied
Change of Drug Categories Number When EDL Applied
(% of physicians)
Perceived Worries And Impact Of “ 零差价” Policy
(% of physicians)
No enough subsidy and government
investment will increase
More treatment will be available in
CHC
CHC staff salary will decrease
CHC income/profit will decrease or
have deficit
No assurance of medicine quality
Who will pay for the balance
Good for patient size increase
Personal career will be influenced
14.0
38.1
47.9
Will
increase
Will not
increase
Not sure
# of Drug
Categories
Tier I Cities Tier II Cities Tier III Cities
Will increase 28.9 62.2 52.9
Will not increase 14.4 12.2 15.3
Not sure 56.7 25.6 31.8
Illustrative

Contents
Sampling Plan
Contents of Report
Cost of Reports

China CHC & THC Market Overview - Supply & Demand
Contents of Report (1/2)
1. Market Overview
− The supply side
Market size, out patients caseload, physicians, number of community centers/hospitals including
number of hospital beds by provinces. Their growth trends including patient caseload during the
past years.
− The demand side
Population demographics, the population is covered by three types of healthcare programs. The
healthcare expenditure.
2. Market Overview - CHC/THC Supply Side
− CHC pharma market: by hospital type and by province
− Number of CHC/THC hospitals by province
− Number of CHC/THC physicians by province
− Number of CHC/THC hospital beds by province
− CHCs & THCs’ outpatient caseload by province

China CHC & THC Market Overview - Supply & Demand
3. Market Overview - CHC/THC Demand Side
− Total CHC/THC catchment population demographic breakdown by province
− CHC/THC population covered by which reimbursement schemes by province
− CHC/THC catchment population’s GDP income status by province
− CHC/THC hospital physicians and their hospital beds ratio by province
− CHC/THC expenditures by province as % of total market spend
− CHC/THC outpatient numbers & visits and average outpatient expenditure by province
4. CHC Market Analysis and Territory Management Strategy
− Concentration of CHC market segments
− Concentration of THC market segments
− Territory management of CHC and THC markets

China CHC Market Opportunities - Physicians & Patients Perspectives
1. Patients & Diseases
− What diseases are treated for in-patients and out-patients
− Key drivers to consult in CHCs rather than big hospitals
(e.g. diagnosis, retention of prescriptions, recheck of lab tests, etc.)
− Current level of doctor and patient satisfaction with CHC services and gap analysis
− Current trends for future services for the CHC market and CHC stations
2. CHCs and CHC Stations
− Analysis of current specialties and those in future to be developed in CHCs
− Analysis of typical current CHC resourcing setup: equipments, lab exams, staff, dispensary
traffic and how current resourcing will look in the future
− Number of medicines in the CHC dispensaries (both Western and TCMs)
− Current pattern of CHC hospital purchasing: direct use of an exclusive or several distributors
− Analysis of the prescriptions of medicines not on the current CHC hospitals’ formulary
2. Physicians
− Number of CHC hospitals’ physicians segmented by their specialties
− CHC staff profile: age, working years, education background, gender and family status.

China CHC Market Opportunities - Physicians & Patients Perspectives
− Typical CHC physicians’ prescription attitudes and behaviors towards patients
− Various formats used for CME (continuous medical education)
− Key issues and current unmet needs of CHC physicians
− CHC physicians’ awareness and perceptions of local brands and MNCs’ brands
4.E-marketing Opportunity of CHC Physicians
− CHC physician’s internet surfing habits
a) Frequency, location
b) Main purposes of internet surfing
c) Regularly visited websites to get medical information
− CHC Physician’s Preference for Online Medical Information
a) Online CME (continuous medical education)
b) Net conference organized by pharma companies
− E-marketing Opportunity for CHC Physician
a) Experience of attending e-marketing activities
b) Willingness to attend e-marketing activities
c) Favorite e-marketing activities (net conference, email, e-detailing, etc)
d) Evaluation and attitude towards e-marketing activities

China THC Market Opportunities, from Physicians and Patients Perspectives

1.Patients & Diseases
− What diseases are treated for in-patients and out-patients
− Key drivers to consult in THCs rather than big hospitals: (e.g. diagnosis, retention of
prescriptions, recheck of lab tests, etc.)
− Current level of doctor and patient satisfaction with THC services and gap analysis
− Current trends for future services for the THC market
2.Basic Facts of THCs
− Analysis of current specialties and those in future to be developed in THCs
− Analysis of typical current THC resourcing setup: equipments, lab exams, staff, dispensary
traffic and how current resourcing will look in the future
− Number of medicines (Western and TCMs) in the THC dispensaries
− Current pattern of THC hospital purchasing: direct use of an exclusive or several distributors
− Analysis of the prescriptions of medicines not on the current THC hospitals’ formulary
3.Physicians
− Number of THC hospitals’ physicians segmented by their specialties
− THC staff profile: age, working years, education background, gender and family status.

China THC Market Opportunities, from Physicians and Patients Perspectives
− Typical THC physicians’ prescription attitudes and behaviors towards patients
− Various formats used for CME (Continuous Medical Education)
− Key issues and current unmet needs of THC physicians
− THC physicians’ awareness and perceptions of local brands and MNCs’ brands
4.E-marketing Opportunity of THC Physicians
− THC physician’s internet surfing habits
a) Frequency, location
b) Main purposes of internet surfing
c) Regularly visited websites to get medical information
− THC Physician’s Preference for Online Medical Information
a) Online CME (continuous medical education)
b) Net conference organized by pharma companies
− E-marketing Opportunity for THC Physician
a) Experience of attending e-marketing activities
b) Willingness to attend e-marketing activities
c) Favorite e-marketing activities (net conference, email, e-detailing, etc)
d) Evaluation and attitude towards e-marketing activities

Contents
Sampling Plan
Contents of Report
Cost of Reports

Cost of Reports
Report Wave 2010 Wave 2013
1. China CHC & THC Market Overview Report
Supply & Demand
100,000 CNY
16,500 USD
100,000 CNY
16,500 USD
2. China CHC Market Opportunities Report
Physicians & Patients
300,000 CNY
45,000 USD
200,000 CNY
33,000 USD
3. China THC Market Opportunities Report
Physicians & Patients
NA 200,000 CNY
33,000 USD
E-marketing opportunities with CHC Physicians 70,000 Cost included in
Report 2
Early bird 10% discount for subscribing :
- to Report 1 before July 15
- to Reports 2 & 3 before August 15
Clients who had subscribed to version 2010 will be offered with special discounts
Please contact your account service managers.

For more information, please contact your Senior Account Service Manager:
Bruno Vayssié
Tel. : +86 21 6290 2121 x 171
Mobile : +86 134 728 725 67
E-mail : bruno.vayssie@loudon-research.com
Thank You!

Intro china chc & thc market reports 2013

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Viewers also liked

Viewers also liked (17)

Similar to Intro china chc & thc market reports 2013

Similar to Intro china chc & thc market reports 2013 (20)

Intro china chc & thc market reports 2013

Editor's Notes